Precision BioSciences (DTIL) News Today $7.44 -0.03 (-0.40%) Closing price 10/29/2026 04:00 PM EasternExtended Trading$7.43 -0.01 (-0.13%) As of 10/29/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Precision BioSciences Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026October 29 at 9:30 AM | finance.yahoo.comPrecision BioSciences (NASDAQ:DTIL) Share Price Breaks Below Two Hundred Day Moving Average - What's Next?October 27 at 4:12 AM | americanbankingnews.comPrecision BioSciences (NASDAQ:DTIL) Stock Price Breaks Below 200 Day Moving Average - Time to Sell?October 27 at 4:00 AM | marketbeat.comPrecision BioSciences (DTIL) Set to Post Earnings on MondayOctober 26, 2026 | americanbankingnews.comPrecision BioSciences (DTIL) Set to Release Earnings on MondayOctober 26, 2026 | marketbeat.comPrecision BioSciences Inc (DTIL)October 13, 2026 | in.investing.comPrecision BioSciences, Inc. (NASDAQ:DTIL) Stock Now Rated "Moderate Buy" by Sell-Side BrokeragesOctober 12, 2026 | marketbeat.comPrecision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026October 8, 2026 | businesswire.comPrecision BioSciences (NASDAQ:DTIL) Director Geno Germano Purchases 2,609 Shares of Company StockSeptember 30, 2026 | insidertrades.comAnalysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Precision BioSciences (DTIL)September 30, 2026 | theglobeandmail.comPrecision Biosciences Inc.September 23, 2026 | barrons.comPrecision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD StudyAugust 24, 2026 | businesswire.comPrecision BioSciences: Promising HBV Editing EvidenceAugust 18, 2026 | seekingalpha.comPrecision BioSciences: Q2 Earnings SnapshotAugust 6, 2026 | chron.comPrecision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business UpdateAugust 6, 2026 | businesswire.comPrecision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026July 31, 2026 | businesswire.comPrecision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical MilestonesJuly 27, 2026 | businesswire.comPrecision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 10, 2026 | businesswire.comPrecision BioSciences Advances Gene-Editing Programs in Hepatitis BJuly 1, 2026 | tipranks.comPrecision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional InvestorsJune 29, 2026 | businesswire.comPrecision BioSciences Announces its Addition to the Russell Microcap® IndexJune 25, 2026 | businesswire.comPrecision BioSciences Extends Term Loan Maturity to 2029June 16, 2026 | tipranks.comPrecision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026May 27, 2026 | businesswire.comPrecision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver ...May 22, 2026 | uk.finance.yahoo.comPrecision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026May 21, 2026 | businesswire.comPrecision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual MeetingMay 14, 2026 | businesswire.comAnalysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Precision BioSciences (DTIL)May 12, 2026 | theglobeandmail.comPrecision BioSciences Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 5, 2026 | businesswire.comPrecision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026April 30, 2026 | businesswire.comPrecision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD StudyApril 29, 2026 | tmcnet.comPrecision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual MeetingApril 28, 2026 | businesswire.comPrecision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)April 24, 2026 | businesswire.comPrecision BioSciences, Inc. (DTIL) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptApril 15, 2026 | seekingalpha.comPrecision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European CountriesApril 15, 2026 | businesswire.comPrecision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare ConferenceApril 8, 2026 | businesswire.comPrecision BioSciences, Inc. (DTIL) Shareholder/Analyst Call TranscriptMarch 17, 2026 | seekingalpha.comH.C. Wainwright Sticks to Its Buy Rating for Precision BioSciences (DTIL)March 12, 2026 | theglobeandmail.comPrecision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business UpdateMarch 12, 2026 | tmcnet.comPrecision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV ProgramMarch 11, 2026 | businesswire.comPrecision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical ...March 10, 2026 | tmcnet.comPrecision BioSciences reports encouraging muscle improvements in preclinical DMD gene therapy studyMarch 10, 2026 | msn.comPrecision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical & Scientific Conference 2026March 10, 2026 | businesswire.comPrecision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026March 9, 2026 | businesswire.comPrecision BioSciences shares jump after FDA grants fast track status to Duchenne therapyMarch 9, 2026 | msn.comPrecision BioSciences stock jumps on FDA Fast Track statusMarch 9, 2026 | za.investing.comPrecision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor EventMarch 9, 2026 | businesswire.comPrecision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple SclerosisMarch 2, 2026 | businesswire.comInsider Selling: Precision BioSciences (NASDAQ:DTIL) Insider Sells $18,912.00 in StockFebruary 20, 2026 | insidertrades.comPrecision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular DystrophyFebruary 11, 2026 | businesswire.comJonesTrading Keeps Their Buy Rating on Precision BioSciences (DTIL)January 24, 2026 | theglobeandmail.com Precision BioSciences Media Mentions By Week Precision BioSciences Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DTIL News Sentiment▼0.550.65▲Average Healthcare News Sentiment Precision BioSciences News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DTIL Articles This Week▼62▲DTIL Articles Average Week Precision BioSciences Trends on MarketBeatThis week vs. last weekNew Followers2+100%Searches2+100%Page Views1,394-28% Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 4D Molecular Therapeutics News Prime Medicine News Sana Biotechnology News Lexicon Pharmaceuticals News Design Therapeutics News Pharming Group News Solid Biosciences News Adlai Nortye News Aura Biosciences News WAVE Life Sciences News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Precision BioSciences dated 10/29/2026. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredTrump’s $16 Trillion Chess Move (signed and highlighted)A newly signed executive order could point to one of the largest resource deals in history, according to Matt ...Monument Traders Alliance | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDO YOU LIVE HERE? ⬇️Data centers now number about 1,300 across the US, with another 2,500 planned. Each can draw as much power as ...Paradigm Press | SponsoredWhy Experts Call This Shift Medicine's Biggest Moment Since AntibioticsA little-known Midwestern firm sits at the center of what the Wall Street Journal calls medicine's biggest mom...Compounding Quality | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
